Lekh N. Dahal

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Sarah L. Buchan, Lang Dou, Marcus Remer et al. · Immunity · 2018 · 145 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Allergy +9

The soluble isoform of CTLA‐4 as a regulator of T‐cell responses

Frank J. Ward, Lekh N. Dahal, Subadra K. Wijesekera et al. · European Journal of Immunology · 2013 · 132 citations

Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo

Ali Roghanian, Ingrid Teige, Linda Mårtensson et al. · Cancer Cell · 2015 · 129 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Antagonistic Human Fcγriib +12

Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies

Xiaojie Yu, H.T. Claude Chan, Christian M. Orr et al. · Cancer Cell · 2018 · 106 citations · Full text

Immunology, Immunodominance, Immunologic Mechanism +18

STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy

Lekh N. Dahal, Lang Dou, Khiyam Hussain et al. · Cancer Research · 2017 · 82 citations · Full text